在英国常规临床实践中，尼达尼布治疗特发性肺纤维化的安全性和耐受性。
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice.
作者信息
Fletcher Sophie V, Jones Mark G, Renzoni Elizabeth A, Parfrey Helen, Hoyles Rachel K, Spinks Katherine, Kokosi Maria, Kwok Apollinaris, Warburton Chris, Titmuss Vanessa, Thillai Muhunthan, Simler Nicola, Maher Toby M, Brereton Christopher J, Chua Felix, Wells Athol U, Richeldi Luca, Spencer Lisa G
机构信息
NIHR Southampton Respiratory Biomedical Research Centre University Hospital Southampton and Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
ILD Unit, Royal Brompton Hospital, London, UK.
出版信息
ERJ Open Res. 2018 Oct 19;4(4). doi: 10.1183/23120541.00049-2018. eCollection 2018 Oct.
Abstract
摘要
http://ow.ly/4HeM30lFS67. （此为网址，一般无需翻译，保留原样即可）
Zotero 插件